Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy

被引：0

作者：

J. De Castro

J. L. González-Larriba

S. Vázquez

B. Massutí

J. M. Sanchez-Torres

M. Dómine

P. Garrido

A. Calles

A. Artal

R. Collado

R. García

M. Sereno

M. Majem

J. A. Macías

O. Juan

J. Gómez-Codina

B. Hernández

M. Lázaro

A. L. Ortega

M. Cobo

J. M. Trigo

E. Carcereny

C. Rolfo

S. Macia

J. Muñoz

P. Diz

M. Méndez

F. Rosillo

L. Paz-Ares

J. V. Cardona

D. Isla

机构：

[1] Hospital Universitario La Paz-IDIPAZ,Medical Oncology Unit––Department of Translational Oncology

[2] Hospital Clínico Universitario San Carlos,undefined

[3] Hospital Universitario Lucus Augusti,undefined

[4] Hospital General Universitario de Alicante,undefined

[5] MD Anderson Cancer Center Madrid,undefined

[6] Fundación Jiménez Díaz,undefined

[7] Hospital Ramón y Cajal,undefined

[8] Centro Integral Oncológico Clara Campal,undefined

[9] Hospital Universitario Miguel Servet,undefined

[10] Hospital San Pedro de Alcántara,undefined

[11] Hospital Universitario Gregorio Marañón,undefined

[12] Hospital Infanta Sofía,undefined

[13] Hospital de la Santa Creu i Sant Pau,undefined

[14] Hospital General Universitario Morales Meseguer,undefined

[15] Hospital Arnau Vilanova,undefined

[16] Hospital La Fe,undefined

[17] Complejo Hospitalario de Navarra––Hospital de Navarra,undefined

[18] Complexo Hospitalario Universitario de Vigo,undefined

[19] Complejo Hospitalario de Jaén,undefined

[20] Hospital Regional Universitario Carlos Haya,undefined

[21] Hospital Universitario Virgen de la Victoria,undefined

[22] Institut Català d’Oncologia-Hospital Universitari Germans Trias i Pujol,undefined

[23] University Hospital of Antwerp,undefined

[24] Hospital General Universitario de Elda,undefined

[25] Hospital Universitario Doctor Peset,undefined

[26] Complejo Asistencial Universitario de León,undefined

[27] Hospital Universitario de Móstoles,undefined

[28] Complejo Hospitalario Torrecárdenas,undefined

[29] Hospital Universitario Virgen del Rocío,undefined

[30] Roche Farma,undefined

[31] S.A.,undefined

[32] Hospital Clínico Universitario Lozano Blesa,undefined

来源：

Clinical and Translational Oncology | 2017年 / 19卷

关键词：

Non-squamous NSCLC; First-line treatment; Bevacizumab; Bevacizumab maintenance therapy; Routine clinical practice setting; Observational study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：219 / 226

页数：7

共 50 条

[1] Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy
De Castro, J.
Gonzalez-Larriba, J. L.
Vazquez, S.
Massuti, B.
Sanchez-Torres, J. M.
Domine, M.
Garrido, P.
Calles, A.
Artal, A.
Collado, R.
Garcia, R.
Sereno, M.
Majem, M.
Macias, J. A.
Juan, O.
Gomez-Codina, J.
Hernandez, B.
Lazaro, M.
Ortega, A. L.
Cobo, M.
Trigo, J. M.
Carcereny, E.
Rolfo, C.
Macia, S.
Munoz, J.
Diz, P.
Mendez, M.
Rosillo, F.
Paz-Ares, L.
Cardona, J. V.
Isla, D.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (02): : 219 - 226
[2] First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer
Bearz, Alessandra
Passalacqua, Rodolfo
Alabiso, Oscar
Cinieri, Saverio
Gridelli, Cesare
Cravesana, Claudia
Crino, Lucio
CLINICAL DRUG INVESTIGATION, 2012, 32 (11) : 755 - 760
[3] Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan
Ahn, Myung-Ju
Tsai, Chun-Ming
Hsia, Te-Chun
Wright, Elaine
Chang, John Wen-Cheng
Kim, Heung Tae
Kim, Joo-Hang
Kang, Jin Hyoung
Kim, Sang-We
Bae, Eun-Jin
Kang, Mijeong
Lister, Johanna
Walzer, Stefan
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 : 22 - 33
[4] First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung CancerAnalysis of the Italian Patients Enrolled in the SAiL Study
Alessandra Bearz
Rodolfo Passalacqua
Oscar Alabiso
Saverio Cinieri
Cesare Gridelli
Claudia Cravesana
Lucio Crinò
Clinical Drug Investigation, 2012, 32 : 755 - 760
[5] Safety of bevacizumab-based therapy as first-line treatment of patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): MO19390 (SAiL)
Dansin, E.
Mezger, J.
Isla, D.
Barlesi, F.
Bearz, A.
Garrido Lopez, P.
Laskin, J. J.
Pavlakis, N.
Thatcher, N.
Crino, L.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[6] Bevacizumab in the first-line therapy of advanced NSCLC
Hasenoehrl, Norbert
WIENER MEDIZINISCHE WOCHENSCHRIFT, 2007, 157 (21-22) : 576 - 578
[7] First-line treatment with gefitinib in combination with bevacizumab and chemotherapy in advanced non-squamous NSCLC with EGFR-mutation
Xiong, Yanjuan
Wang, Lu
Zhang, Weihong
Meng, Yuan
Wang, Yang
Shen, Meng
Zhou, Li
Li, Runmei
Lv, Yingge
Wang, Shengguang
Ren, Xiubao
Liu, Liang
BMC CANCER, 2024, 24 (01)
[8] Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy
Demircan, Nazim Can
Dane, Faysal
Ozturk, Mehmet Akif
Babacan, Nalan Akgul
Besiroglu, Mehmet
Kaya, Serap
Ercelep, Ozlem
Tanrikulu, Eda
Halil, Suleyman
Koca, Sinan
Alan, Ozkan
Hasano, Rahip
Yumuk, Perran Fulden
JOURNAL OF BUON, 2019, 24 (04): : 1494 - 1500
[9] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
Patel, J. D.
Hensing, T. A.
Rademaker, F.
Hart, E.
Obasaju, C. K.
Treat, J.
Milton, D.
Bonomi, P. D.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[10] Patients with advanced Non-Squamous NSCLC: Experience with Bevacizumab in the continuous Maintenance Therapy
Bornkessel, Barbara
ONKOLOGIE, 2012, 35 (06): : 395 - 395

← 1 2 3 4 5 →